TScan Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has TScan Therapeutics's balance sheet done over the years? Its assets were worth $272,149,000 last year, which is more than in the previous period. 45% of TScan Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $121,282,000, which means an increase by 22% compared compared to last year.

Debt to Assets

TScan Therapeutics, Inc. (NASDAQ:TCRX): Debt to assets
2019 49383000 66.52M 134.7%
2020 49738000 92.2M 185.37%
2021 188107000 27.32M 14.53%
2022 199091000 99.65M 50.06%
2023 272149000 121.28M 44.56%

TCRX Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
133.35M120.02M161.40M34.79M41.76M
Short term investments
58.68M0000
Net receivables
00000
Inventory
00000
Other current assets
2.19M4.1M4.24M1.65M615K
Total current assets
194.23M120.02M165.65M36.44M42.37M
Non-current assets:
Property, Plant and Equipment
71.23M69.20M17.25M12.53M6.40M
Goodwill
00000
Intangible assets
00000
Long term investments
05.03M5.19M761K595K
Other non-current assets
6.67M4.82M000
Total non-current assets
77.91M79.06M22.45M13.29M7.00M
Total assets
272.14M199.09M188.10M49.73M49.38M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
10.13M3.87M11.41M10.62M912K
Short term debt
9.83M3.68M1.65M1.41M443K
Total current liabilities
29.82M17.30M21.34M17.44M2.39M
Non-current liabilities:
Long term debt
85.84M82.30M4.39M6.01M4.44M
Deferred tax
00000
Other non-current liabilities
049K97K238K59.68M
Total non-current liabilities
91.46M82.35M5.98M74.75M64.12M
Total liabilities
121.28M99.65M27.32M92.2M66.52M
Data sourceData sourceData source